Tyndall Capital Partners’s Cyclerion Therapeutics CYCN Stock Holding History

Tyndall Capital Partners’s Portfolio CYCN Stock Details CYCN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$452K	Sell
2025 Q1	$412K	Hold
2024 Q4	$531K	Hold
2024 Q3	$427K	Hold
2024 Q2	$379K	Hold
2024 Q1	$527K	Buy
2023 Q4	$551K	Buy
2023 Q3	$505K	Buy